Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Lars Normann Karlsen

Subtherapeutic Concentrations of Infliximab and Adalimumab Are Associated With Increased Disease Activity in Crohn’s Disease

Therapeutic Advances in Gastroenterology

Gastroenterology

English

Related publications

Infliximab Versus Adalimumab in Patients With Biologic-Naïve Crohn’s Disease: Is the Difference Real?

Digestive Diseases and Sciences

Gastroenterology

English

Infliximab and Adalimumab Drug Levels in Crohn's Disease: Contrasting Associations With Disease Activity and Influencing Factors

Alimentary Pharmacology and Therapeutics

Gastroenterology

English

Cost-Minimization Analysis of Infliximab Versus Adalimumab in the Treatment of Crohn’s Disease and Ulcerative Colitis

Value in Health

Occupational Health

English

Clinical and Pharmacokinetic Factors Associated With Adalimumab-Induced Mucosal Healing in Patients With Crohn’s Disease

Clinical Gastroenterology and Hepatology

Gastroenterology

English

D-Dimer Levels Are Correlated With Disease Activity in Crohn’s Patients

English

Crohn’s Disease and Ulcerative Colitis Are Associated With Elevated Standardized Mortality Ratios

Inflammatory Bowel Diseases

Gastroenterology

English

Immunogenicity Negatively Influences the Outcome of Adalimumab Treatment in Crohn’s Disease

Alimentary Pharmacology and Therapeutics

Gastroenterology

English

Comparison of Scheduled and Episodic Treatment Strategies of Infliximab in Crohn’s Disease

Gastroenterology

Gastroenterology

English

Higher Infliximab Trough Levels Are Associated With Perianal Fistula Healing in Patients With Crohn's Disease

Alimentary Pharmacology and Therapeutics

Gastroenterology

English